Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases From Small Cell Lung Cancer

NCT04804644 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT04804644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases From Small Cell Lung Cancer
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 8, 2021
Completion date
July 1, 2031
Enrollment
152 (actual)
Sites
231

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung small cell carcinoma, metastatic malignant neoplasm in the brain, recurrent lung small cell carcinoma, stage iv lung cancer ajcc v8